import Navbar from '@/components/Navbar';
import Footer from '@/components/Footer';
import { Link } from 'react-router-dom';
import { SEOHead } from '@/components/seo/SEOHead';
import { BreadcrumbNav } from '@/components/seo/BreadcrumbNav';
import { FAQSection } from '@/components/healthcare-research/FAQSection';
import { buildBreadcrumbSchema } from '@/lib/seo/schemas';
import { GeoLLMAnswerBlock } from '@/components/seo/GeoLLMAnswerBlock';
import { getStandaloneReportConfig } from '@/data/reportConversionConfig';
import { MarketIntelligenceSections } from '@/components/market-intelligence';
import { buildReportEnrichmentSchemas } from '@/lib/reportEnrichmentSchemas';
import {
  ReportConsultationBand,
  ReportContentWithAside,
  ReportMidPageCta,
  ReportReadingProgress,
} from '@/components/report-conversion';
import { ReportPremiumHero } from '@/components/report-premium';
import { finalizeStandaloneMedDeviceFaqs } from '@/data/standaloneCountryReportContent';

const breadcrumbItems = [
  { name: 'Home', href: '/' },
  { name: 'GCC Medical Devices Market Report', href: '/gcc-medical-devices-market-report' },
];

const REPORT_FAQ_ITEMS = finalizeStandaloneMedDeviceFaqs([
  {
    question: 'How big is the GCC medical devices market in 2026?',
    answer:
      'The GCC medical devices market is estimated at USD 9.0 billion in 2026, projected to reach USD 16.2 billion by 2035 at approximately 6.7% CAGR (Market Research Future). Saudi Arabia leads with ~51% regional share (USD 4.4–4.8B), followed by the UAE (~26%, USD 2.2–2.5B). Qatar, Kuwait, Bahrain, and Oman account for the remaining ~23%. Growth is driven by hospital capacity expansion under Vision 2030, rising chronic disease incidence, and increased private sector healthcare participation.',
  },
  {
    question: 'Which country has the largest medical device market in the GCC?',
    answer:
      'Saudi Arabia has the GCC\'s largest medical devices market at USD 4.4–4.8 billion (2026 estimate), representing roughly half of total regional spend. Saudi Arabia\'s dominance reflects its large population (37 million), Vision 2030\'s SAR 500 billion healthcare infrastructure commitment, and a hospital network spanning MOH, NGHA, SANG, KFSH&RC, and the rapidly expanding private hospital sector in Riyadh, Jeddah, and the Eastern Province.',
  },
  {
    question: 'What are the fastest-growing medical device categories in the GCC?',
    answer:
      'The five fastest-growing GCC medical device categories are: (1) Minimally invasive surgical systems — robotic surgery adoption accelerating at major academic centers; (2) Point-of-care diagnostics — HbA1c, cardiac biomarkers, and infectious disease rapid tests scaling with decentralized care models; (3) Continuous glucose monitoring — GCC\'s high diabetes prevalence driving CGM uptake in Saudi Arabia and UAE; (4) AI-powered imaging equipment — driving diagnostic upgrade cycles across radiology departments; and (5) Home healthcare devices — remote patient monitoring accelerating post-COVID.',
  },
  {
    question: 'What are the medical device regulatory requirements across GCC countries?',
    answer:
      'GCC medical device regulation varies by country: Saudi Arabia requires SFDA registration under the MDIR framework (Class A notification, Class B–D technical review, 6–18 month timelines). UAE requires MOHAP registration with parallel DHA and DOH approval for emirate-specific access. Qatar requires MOPH registration, with Hamad Medical Corporation operating independent procurement evaluation. Kuwait (MOPH), Bahrain (NHRA), and Oman (MOH) each operate country-specific registration processes. NHRA Bahrain offers mutual recognition for Saudi and UAE-registered products. BioNixus maps regulatory timelines and listing requirements across all six markets.',
  },
  {
    question: 'Who are the top medical device companies operating in the GCC?',
    answer:
      'The GCC medical devices market is served by the full spectrum of global OEMs: imaging and diagnostics leaders include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Mindray (growing share in mid-tier hospital segment). Cardiovascular device leaders include Medtronic, Abbott, Boston Scientific, and Edwards Lifesciences. Surgical systems are led by Intuitive Surgical, Stryker, Zimmer Biomet, and Johnson & Johnson MedTech. Local distribution is managed through registered Saudi and UAE agents including Al-Faisaliah, AMSCO, and Cigalah.',
  },
  {
    question: 'How does BioNixus support medical device market strategy in the GCC?',
    answer:
      'BioNixus supports GCC medical device commercial strategy through three primary intelligence products: (1) Account-level procurement intelligence — hospital-specific budget cycles, procurement head contacts, and device replacement schedules sourced from biomedical engineering and procurement department primary research; (2) Clinical user research — quantitative and qualitative surveys with surgeons, intensivists, radiologists, and clinical engineers mapping device preference, switching barriers, and competitive positioning; and (3) Regulatory and access tracking — systematic monitoring of SFDA, MOHAP, DHA, and DOH device registration timelines, approval outcomes, and formulary listing status.',
  },
], 'gcc');

const REPORT_CONVERSION = getStandaloneReportConfig('/gcc-medical-devices-market-report');
const FAQ_SECTION_ID = 'gcc-medical-devices-faq';

const jsonLd = [
  buildBreadcrumbSchema(breadcrumbItems),
  {
    '@context': 'https://schema.org',
    '@type': 'Article',
    headline: 'GCC Medical Devices Market Report 2026: Size, Segments, and Hospital Procurement Intelligence',
    author: {
      '@type': 'Person',
      name: 'Laura Williams',
      jobTitle: 'Research Director',
      worksFor: { '@type': 'Organization', name: 'BioNixus Healthcare Market Research' },
    },
    publisher: {
      '@type': 'Organization',
      name: 'BioNixus',
      logo: { '@type': 'ImageObject', url: 'https://www.bionixus.com/bionixus-logo.webp' },
    },
    datePublished: '2026-05-01',
    dateModified: '2026-07-21',
    mainEntityOfPage: 'https://www.bionixus.com/gcc-medical-devices-market-report',
  },
  {
    '@context': 'https://schema.org',
    '@type': 'FAQPage',
    url: `https://www.bionixus.com/gcc-medical-devices-market-report#${FAQ_SECTION_ID}`,
    mainEntity: REPORT_FAQ_ITEMS.map((item) => ({
      '@type': 'Question',
      name: item.question,
      acceptedAnswer: { '@type': 'Answer', text: item.answer },
    })),
  },
  ...buildReportEnrichmentSchemas({
    pageTitle: "GCC Medical Devices Market Report 2026 | USD 9.0B Market Size, Segments & Intelligence | BioNixus",
    pageMetaDescription: "GCC medical devices market at USD 9.0B in 2026, reaching $16.2B by 2035 (6.7% CAGR, Market Research Future). Saudi Arabia, UAE, and Kuwait country-level data, regulatory requirements (SFDA, MOHAP, DHA), device segments, and hospital procurement intelligence from BioNixus.",
    countryName: "GCC",
    marketSlug: "gcc",
    publishedDate: "2026-05-01",
    modifiedDate: "2026-07-21",
  })
];

function StatCard({ value, label }: { value: string; label: string }) {
  return (
    <div>
      <p className="text-3xl font-display font-bold text-primary">{value}</p>
      <p className="text-xs text-muted-foreground mt-1">{label}</p>
    </div>
  );
}

const GccMedicalDevicesMarketReport = () => {
  return (
    <div className="min-h-screen bg-background">
      <Navbar />

      <SEOHead
        title="GCC Medical Devices Market 2026: Size, Share & Country Forecasts"
        description="GCC medical device market report 2026 — Saudi, UAE, Qatar, Kuwait, Oman & Bahrain market sizes, regulations and forecasts. By BioNixus."
        canonical="https://www.bionixus.com/gcc-medical-devices-market-report"
        jsonLd={jsonLd}
      />
      <ReportReadingProgress progressId="report-rp-gcc-medical-devices-market-report" />
      <main>
        <div className="section-padding pt-24 pb-4">
          <div className="container-wide">
            <BreadcrumbNav items={breadcrumbItems} />
          </div>
        </div>

        {/* Hero */}
                <ReportPremiumHero
          title="GCC Medical Devices Market 2026: IVD, Prefilled Syringes & Hospital Procurement"
          description="BioNixus delivers account-level medical device procurement intelligence, clinical user research, and regulatory access mapping across Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, and Oman — enabling medtech and device companies to size markets, prioritize accounts, and accelerate commercial entry."
          config={REPORT_CONVERSION}
          marketSlug="gcc"
          countryName="GCC"
          stats={[
            { value: '~$9.0B', label: 'GCC medical devices market 2026 (est.)' },
            { value: '$16.2B', label: 'Forecast by 2035' },
            { value: '6.7%', label: 'CAGR 2026–2035' },
          ]}
        />

        <section className="section-padding py-8 bg-muted/10">
          <div className="container-wide max-w-4xl mx-auto">
            <GeoLLMAnswerBlock
              question="How big is the GCC medical devices and IVD market in 2026?"
              answer="The GCC medical devices and in vitro diagnostic (IVD) market is estimated at USD 9.0 billion in 2026, reaching USD 16.2 billion by 2035 at approximately 6.7% CAGR (Market Research Future). Saudi Arabia represents roughly 51% of regional spend, the UAE about 26%, and Qatar, Kuwait, Bahrain, and Oman accounting for the remainder. Growth drivers include Vision 2030 hospital expansion, rising diabetes and cardiovascular burden, and SFDA/MOHAP device registration reforms."
              points={[
                {
                  title: 'Saudi Arabia leadership',
                  description:
                    'USD 4.4–4.8B medtech spend anchored in MOH, NGHA, and private hospital networks across Riyadh, Jeddah, and the Eastern Province.',
                },
                {
                  title: 'IVD and point-of-care acceleration',
                  description:
                    'HbA1c, cardiac biomarker, and infectious disease rapid tests scaling with decentralized care and diabetes prevalence.',
                },
                {
                  title: 'Regulatory pathways',
                  description:
                    'SFDA MDIR, UAE MOHAP/DHA/DOH, and NHRA Bahrain registration timelines mapped for launch sequencing.',
                },
                {
                  title: 'Hospital procurement intelligence',
                  description:
                    'Account-level budget cycles, biomedical engineering contacts, and device replacement schedules from primary research.',
                },
              ]}
              summary="BioNixus GCC medical devices market report combines sizing with hospital procurement intelligence — request a tailored medtech scope through contact."
            />
          </div>
        </section>

        {/* Executive Summary */}
        <ReportContentWithAside config={REPORT_CONVERSION}>
        <section className="section-padding bg-cream-dark" id="executive-summary">
          <div className="container-wide max-w-4xl mx-auto">
            <h2 className="text-2xl md:text-3xl font-display font-semibold text-foreground mb-6">
              Executive Summary
            </h2>
            <div className="bg-white rounded-xl border border-border p-6 shadow-sm mb-6">
              <div className="grid sm:grid-cols-3 gap-6 text-center">
                <StatCard value="~$9.0B" label="GCC medical devices market 2026 (est.)" />
                <StatCard value="$16.2B" label="Forecast by 2035" />
                <StatCard value="6.7%" label="CAGR 2026–2035" />
              </div>
            </div>
            <p className="text-muted-foreground leading-relaxed mb-4">
              Market Research Future sizes the GCC medical devices market at USD 9.0 billion in 2026, reaching USD 16.2 billion by 2035 — one of the fastest-growing major medical devices regions globally on a
              percentage basis. Vision 2030 in Saudi Arabia, UAE Vision 2031, and National Health Strategies
              across Qatar, Kuwait, Bahrain, and Oman are collectively deploying hundreds of billions in
              healthcare capital — the vast majority of which flows through hospital infrastructure that directly
              drives medical device procurement.
            </p>
            <p className="text-muted-foreground leading-relaxed mb-4">
              Saudi Arabia and the UAE account for approximately 80% of GCC medical device spend. Both markets
              are shifting from predominantly public-sector government-funded procurement toward a hybrid model
              in which private hospital groups, medical insurance-funded spending, and medical tourism revenue
              are creating new and accessible commercial channels.
            </p>
            <p className="text-muted-foreground leading-relaxed">
              For country-specific pharmaceutical market intelligence, see BioNixus's{' '}
              <Link to="/gcc-pharma-market-report-2026" className="text-primary hover:underline font-medium">
                GCC Pharmaceutical Market Report 2026
              </Link>{' '}
              and the{' '}
              <Link to="/saudi-arabia-medical-devices-market-report" className="text-primary hover:underline font-medium">
                Saudi Arabia Medical Devices Market Report
              </Link>. For a deep dive into the diagnostics segment, read our analysis of the{' '}
              <Link to="/blog/saudi-arabia-in-vitro-diagnostics-market" className="text-primary hover:underline font-medium">
                in vitro diagnostics (IVD) market in Saudi Arabia
              </Link>{' '}
              — SFDA registration, molecular diagnostics, and NUPCO procurement.
            </p>
          </div>
        </section>

        {/* Country Market Overview */}
        <section className="section-padding" id="country-overview">
          <div className="container-wide max-w-4xl mx-auto">
            <h2 className="text-2xl md:text-3xl font-display font-semibold text-foreground mb-8">
              GCC Country-Level Medical Devices Market
            </h2>
            <div className="space-y-4">
              {[
                {
                  country: 'Saudi Arabia',
                  size: 'USD 4.4–4.8B (2026 est.)',
                  forecast: 'USD 8.0–8.8B by 2035',
                  cagr: '~6.9% CAGR 2026–2035',
                  regulatory: 'SFDA',
                  detail: 'MOH hospital network (240+ facilities), NGHA, KFSH&RC, and private hospital groups form the procurement landscape. Vision 2030 is adding 30,000+ hospital beds, driving diagnostic imaging, OR equipment, ICU monitoring, and consumables procurement at scale. NUPCO manages centralized MOH procurement; private hospitals tender independently.',
                  link: '/pharmaceutical-companies-saudi-arabia',
                  linkLabel: 'Pharmaceutical companies in Saudi Arabia',
                },
                {
                  country: 'United Arab Emirates',
                  size: 'USD 2.2–2.5B (2026 est.)',
                  forecast: 'USD 4.3–4.9B by 2035',
                  cagr: '~7.6% CAGR 2026–2035',
                  regulatory: 'MOHAP / DHA / DOH',
                  detail: 'Private sector dominant at ~70% of device spend. Dubai functions as the MEA regional distribution hub for most global OEMs. Medical tourism at Cleveland Clinic Abu Dhabi, Mediclinic City, and UAE healthcare clusters drives premium device consumption. Three parallel regulatory pathways (MOHAP, DHA, DOH) require structured registration strategy.',
                  link: '/pharmaceutical-companies-uae',
                  linkLabel: 'Pharmaceutical companies in the UAE',
                },
                {
                  country: 'Kuwait',
                  size: 'USD 750–850M (2026 est.)',
                  forecast: 'USD 1.1–1.25B by 2035',
                  cagr: '~4.3% CAGR 2026–2035',
                  regulatory: 'MOPH Kuwait',
                  detail: 'Central Medical Stores dominates procurement (~85% of volume). Government hospital upgrade programs are creating capital equipment opportunities in imaging and OR technology. Local agent structure is concentrated among a small number of approved distributors.',
                  link: '/pharmaceutical-companies-kuwait',
                  linkLabel: 'Pharmaceutical companies in Kuwait',
                },
                {
                  country: 'Qatar',
                  size: 'USD 680–760M (2026 est.)',
                  forecast: 'USD 1.2–1.4B by 2035',
                  cagr: '~6.5% CAGR 2026–2035',
                  regulatory: 'MOPH Qatar',
                  detail: 'Hamad Medical Corporation is the primary procurement authority. Qatar is investing in specialty care expansion — oncology centers, heart hospitals, and rehabilitation facilities — driving specialty device demand. Post-FIFA World Cup healthcare infrastructure investment continues.',
                  link: '/pharmaceutical-companies-qatar',
                  linkLabel: 'Pharmaceutical companies in Qatar',
                },
                {
                  country: 'Bahrain & Oman',
                  size: 'USD 500–580M combined',
                  forecast: 'USD 690–800M by 2035',
                  cagr: '~3.7% CAGR 2026–2035',
                  regulatory: 'NHRA (Bahrain) / MOH (Oman)',
                  detail: 'Bahrain NHRA offers mutual recognition for SFDA and MOHAP-registered devices, simplifying registration for products already cleared in Saudi Arabia or UAE. Oman\'s Vision 2040 private healthcare participation targets are gradually opening channels.',
                  link: '/pharmaceutical-companies-bahrain',
                  linkLabel: 'Pharmaceutical companies in Bahrain',
                  secondLink: '/pharmaceutical-companies-oman',
                  secondLinkLabel: 'Pharmaceutical companies in Oman',
                },
              ].map(({ country, size, forecast, cagr, regulatory, detail, link, linkLabel, secondLink, secondLinkLabel }) => (
                <div key={country} className="bg-white rounded-xl border border-border p-6 shadow-sm">
                  <div className="flex flex-wrap gap-2 items-center mb-3">
                    <h3 className="text-lg font-display font-semibold text-foreground mr-2">{country}</h3>
                    <span className="inline-flex items-center px-3 py-1 rounded-full bg-primary/10 text-primary text-xs font-medium">
                      {size}
                    </span>
                    <span className="inline-flex items-center px-3 py-1 rounded-full bg-emerald-50 text-emerald-700 text-xs font-medium">
                      {forecast}
                    </span>
                    <span className="inline-flex items-center px-3 py-1 rounded-full bg-amber-50 text-amber-700 text-xs font-medium">
                      {cagr}
                    </span>
                    <span className="inline-flex items-center px-3 py-1 rounded-full bg-slate-100 text-slate-600 text-xs font-medium">
                      {regulatory}
                    </span>
                  </div>
                  <p className="text-sm text-muted-foreground leading-relaxed mb-3">{detail}</p>
                  <p className="text-sm">
                    <Link to={link} className="text-primary hover:underline font-medium">{linkLabel}</Link>
                    {secondLink && (
                      <>
                        {' · '}
                        <Link to={secondLink} className="text-primary hover:underline font-medium">{secondLinkLabel}</Link>
                      </>
                    )}
                  </p>
                </div>
              ))}
            </div>
          </div>
        </section>

        {/* Segments */}
        <section className="section-padding bg-cream-dark" id="device-segments">
          <div className="container-wide max-w-4xl mx-auto">
            <h2 className="text-2xl md:text-3xl font-display font-semibold text-foreground mb-8">
              GCC Medical Device Market Segments
            </h2>
            <div className="grid md:grid-cols-2 gap-6">
              {[
                {
                  segment: 'Diagnostic Imaging',
                  share: '~28% of market value',
                  body: 'MRI, CT, ultrasound, and fluoroscopy systems represent the highest value segment. Saudi Arabia is running the largest radiology capacity expansion program in the region — BioNixus tracks capital equipment procurement cycles by hospital.',
                },
                {
                  segment: 'Cardiovascular Devices',
                  share: '~22% of market value',
                  body: 'Stents, pacemakers, heart valves, and interventional cardiology devices. GCC\'s high cardiovascular disease burden and rising interventional cardiology capacity drive this segment. Medtronic, Abbott, and Boston Scientific dominate.',
                },
                {
                  segment: 'Surgical Instruments & Robotics',
                  share: '~18% of market value',
                  body: 'Robotic-assisted surgery adoption is accelerating at KFSH&RC and Cleveland Clinic Abu Dhabi. Minimally invasive laparoscopic and endoscopic tools are the highest-volume surgical category.',
                },
                {
                  segment: 'In-Vitro Diagnostics',
                  share: '~16% of market value',
                  body: 'Laboratory analyzers, point-of-care testing, and molecular diagnostics. Saudi Arabia\'s national diabetes and CVD screening programs are key volume drivers. Mindray gaining share in mid-tier hospital laboratory segment.',
                },
                {
                  segment: 'Patient Monitoring',
                  share: '~10% of market value',
                  body: 'ICU, HDU, and step-down monitoring systems. GCC\'s hospital capacity expansion is driving monitoring equipment procurement at scale. Connected monitoring and remote patient monitoring growing rapidly.',
                },
                {
                  segment: 'Diabetes Devices',
                  share: '~6% of market value',
                  body: 'CGM and insulin delivery devices. GCC\'s 18%+ diabetes prevalence rate and growing device reimbursement in Saudi Arabia and UAE create a structurally large and rapidly expanding segment.',
                },
              ].map(({ segment, share, body }) => (
                <div key={segment} className="bg-white rounded-xl border border-border p-5 shadow-sm">
                  <div className="flex justify-between items-start mb-2">
                    <h3 className="text-base font-display font-semibold text-foreground">{segment}</h3>
                    <span className="text-xs font-medium text-primary ml-2 shrink-0">{share}</span>
                  </div>
                  <p className="text-sm text-muted-foreground leading-relaxed">{body}</p>
                </div>
              ))}
            </div>
          </div>
        </section>

        {/* Top Companies */}
        <section className="section-padding" id="top-companies">
          <div className="container-wide max-w-4xl mx-auto">
            <h2 className="text-2xl md:text-3xl font-display font-semibold text-foreground mb-6">
              Top Medical Device Companies Operating in the GCC
            </h2>
            <p className="text-muted-foreground leading-relaxed mb-6">
              Global OEMs supply the large majority of GCC hospital device spend, distributed through registered Saudi and UAE agents. BioNixus tracks installed base, distributor relationships, and account-level procurement cycles for each of the companies below.
            </p>
            <div className="overflow-x-auto rounded-xl border border-border shadow-sm">
              <table className="w-full text-sm text-left border-collapse">
                <thead className="bg-cream-dark">
                  <tr>
                    <th scope="col" className="p-4 font-display font-semibold text-foreground">Company</th>
                    <th scope="col" className="p-4 font-display font-semibold text-foreground">Segment</th>
                    <th scope="col" className="p-4 font-display font-semibold text-foreground">GCC Position</th>
                  </tr>
                </thead>
                <tbody className="divide-y divide-border bg-white">
                  {[
                    { company: 'Siemens Healthineers', segment: 'Diagnostic imaging', position: 'Leading imaging OEM across MOH, NGHA, and private hospital tenders' },
                    { company: 'GE Healthcare', segment: 'Diagnostic imaging', position: 'Major imaging and patient monitoring supplier; strong Saudi and UAE installed base' },
                    { company: 'Philips Healthcare', segment: 'Diagnostic imaging & monitoring', position: 'Imaging, monitoring, and connected-care equipment across GCC hospital networks' },
                    { company: 'Mindray', segment: 'Diagnostic imaging & IVD', position: 'Growing share in the mid-tier hospital and laboratory segment' },
                    { company: 'Medtronic', segment: 'Cardiovascular & surgical', position: 'Leading cardiac rhythm management and interventional cardiology supplier' },
                    { company: 'Abbott', segment: 'Cardiovascular & diagnostics', position: 'Structural heart, diabetes care, and point-of-care diagnostics' },
                    { company: 'Boston Scientific', segment: 'Cardiovascular', position: 'Interventional cardiology and electrophysiology devices' },
                    { company: 'Edwards Lifesciences', segment: 'Cardiovascular', position: 'TAVR and structural heart devices at leading GCC cardiac centres' },
                    { company: 'Intuitive Surgical', segment: 'Surgical robotics', position: 'da Vinci systems installed at KFSH&RC, Cleveland Clinic Abu Dhabi, and leading private hospitals' },
                    { company: 'Stryker', segment: 'Surgical & orthopaedics', position: 'Orthopaedic implants and surgical instrumentation across MOH and private networks' },
                    { company: 'Zimmer Biomet', segment: 'Orthopaedics', position: 'Joint replacement and orthopaedic device supply' },
                    { company: 'Johnson & Johnson MedTech', segment: 'Surgical & orthopaedics', position: 'Broad surgical, orthopaedic, and vision-care device portfolio' },
                  ].map((row) => (
                    <tr key={row.company}>
                      <td className="p-4 font-medium text-foreground whitespace-nowrap">{row.company}</td>
                      <td className="p-4 text-muted-foreground">{row.segment}</td>
                      <td className="p-4 text-muted-foreground">{row.position}</td>
                    </tr>
                  ))}
                </tbody>
              </table>
            </div>
            <p className="text-xs text-muted-foreground mt-3">
              Local distribution is managed through registered Saudi and UAE agents including Al-Faisaliah, AMSCO, and Cigalah. Source: BioNixus primary research and hospital procurement mapping, 2026.
            </p>
          </div>
        </section>

        {/* How BioNixus is Different */}
        <section className="section-padding" id="data-methodology">
          <div className="container-wide max-w-4xl mx-auto">
            <h2 className="text-2xl md:text-3xl font-display font-semibold text-foreground mb-6">
              How BioNixus Medical Device Intelligence Is Different
            </h2>
            <p className="text-muted-foreground leading-relaxed mb-6">
              Published GCC medical device market reports rely on import statistics, distributor revenue surveys,
              and expert interviews — producing useful total-market figures but limited account-level,
              procurement-cycle, or clinical user intelligence. BioNixus operates at a fundamentally different
              level of resolution.
            </p>
            <div className="space-y-4">
              {[
                {
                  level: 'Account Level',
                  description: 'Hospital-specific device procurement budgets, installed base mapping, replacement cycle timing, and procurement contact identification across MOH, NGHA, and private hospital networks.',
                },
                {
                  level: 'Clinical User Level',
                  description: 'Primary research with surgeons, radiologists, intensivists, biomedical engineers, and procurement leads — mapping device preference drivers, switching barriers, and competitive positioning at the clinical decision level.',
                },
                {
                  level: 'Regulatory Level',
                  description: 'Systematic tracking of SFDA, MOHAP, DHA, and DOH device registration timelines, approval outcomes, and formulary listing status — delivering advance visibility into competitive access timelines.',
                },
                {
                  level: 'Tender and Procurement Level',
                  description: 'NUPCO Saudi Arabia tender schedule tracking, UAE government hospital procurement cycle intelligence, and private hospital capital equipment budget cycle mapping.',
                },
              ].map(({ level, description }) => (
                <div key={level} className="flex gap-4">
                  <div className="shrink-0 w-32 text-xs font-semibold text-primary pt-1">{level}</div>
                  <p className="text-sm text-muted-foreground leading-relaxed">{description}</p>
                </div>
              ))}
            </div>
          </div>
        </section>

        <MarketIntelligenceSections marketSlug="gcc" countryName="GCC" variant="medical-devices" />

        </ReportContentWithAside>

                <section className="section-padding" id="related-intelligence">
          <div className="container-wide max-w-4xl mx-auto">
            <h2 className="text-2xl md:text-3xl font-display font-semibold text-foreground mb-6">Related BioNixus market intelligence</h2>
            <p className="text-muted-foreground leading-relaxed">
              BioNixus runs medical device and MedTech market research across the GCC. Compare the GCC device market with our{' '}
              <Link to="/saudi-arabia-medical-devices-market-report" className="text-primary hover:underline font-medium">Saudi Arabia medical devices market report</Link>{' '}and{' '}
              <Link to="/uae-medical-devices-market-report" className="text-primary hover:underline font-medium">UAE medical devices market report</Link>, set it against the{' '}
              <Link to="/gcc-pharma-market-report-2026" className="text-primary hover:underline font-medium">GCC pharmaceutical market report</Link>, or widen the lens with the{' '}
              <Link to="/qatar-medical-devices-market-report" className="text-primary hover:underline font-medium">Qatar medical devices market report</Link>. For methods and global coverage, see the{' '}
              <Link to="/healthcare-market-research" className="text-primary hover:underline font-medium">global healthcare market research hub</Link>{' '}and our{' '}
              <Link to="/market-research-healthcare" className="text-primary hover:underline font-medium">healthcare market research services</Link>.
            </p>
            <ReportMidPageCta config={REPORT_CONVERSION} className="mt-8" />
          </div>
        </section>

        <FAQSection
          sectionId={FAQ_SECTION_ID}
          title="GCC medical devices market 2026 — size, segments, regulation, and commercial strategy FAQ"
          items={REPORT_FAQ_ITEMS}
          className="bg-muted/30"
        />

        {/* CTA */}
        <ReportConsultationBand config={REPORT_CONVERSION} />
        </main>

      <Footer />
    </div>
  );
};

export default GccMedicalDevicesMarketReport;
